Daewoong Promotes Advanced Combination Aesthetic Procedures at ‘AMUSE 2025’ in Indonesia
(Jakarta, June 17th, 2025)
Daewoong Pharmaceutical and CGBIO Indonesia are participating in Indonesia’s leading aesthetic medicine congress, ‘AMUSE 2025 (Aesthetic Medicine Updates Seminar and Exhibition),’ to introduce educational programs featuring combination procedures utilizing Daewoong’s aesthetic product lineup, including Nabota.
‘AMUSE 2025’ is organized by the Jakarta Science Academy and will be held from June 17 to 22, 2025, across Jakarta and Tangerang. The event is expected to attract approximately 1,200 doctors, including dermatologists, plastic surgeons, and other aesthetic medicine professionals.
At this event, Daewoong Pharmaceutical, in collaboration with CGBIO Indonesia, will operate a joint exhibition booth under the vision of “Move to NEW GEN,” showcasing innovative combination procedure solutions for the Indonesian aesthetic market. The booth will feature Daewoong’s flagship aesthetic products, including: ▲Nabota (botulinum toxin), ▲Facetem (a skin booster formulated with calcium hydroxyapatite, CaHA), ▲DCLASSY (HA filler), and ▲LUXX (PDO suture thread). Attendees will have the opportunity to experience the unique features of each product and explore their synergistic potential through combination treatments.
In particular, Daewoong invited leading Korean aesthetic medicine experts with extensive clinical and procedural experience in Nabota to the congress, providing Indonesian healthcare professionals with a hands-on, practice-oriented training program. During the workshop and lecture sessions, Dr. Kyung-tae Bae from It’s Me Clinic Sejong will conduct a live demonstration of Nabota procedures for the lower face and neck, providing practical coaching on key indications such as masseter hypertrophy. Dr. Jae-yoon Jung from Oaro Dermatology Clinic will deliver a lecture on advanced combination procedures using Nabota and the CaHA-based skin booster Facetem, sharing the latest trends and clinical insights into skin texture improvement.
To further strengthen educational and marketing capabilities in the aesthetic field, Daewoong Pharmaceutical and CGBIO Indonesia have established the Korea-Indonesia Integrated Marketing Operation Taskforce (KIIMOT). KIIMOT will collaboratively develop combination procedure content tailored to the medical environments and market characteristics of both countries, while building a field-oriented, advanced training system to foster global-level expertise in aesthetics. KIIMOT’s initiatives will revolve around the DEEP (Daewoong Expert Education Program), a global expert training program that embodies Daewoong’s medical aesthetics know-how. Through the continued operation of DEEP, the program aims to systematize clinical experience for Indonesian healthcare professionals, improve procedural skills and product understanding, and ultimately strengthen the spread of differentiated combination procedures and global competitiveness.
Changwoo Ha, Head of the Aesthetic Business Division at KIIMOT, stated, “Participating in AMUSE 2025 is a valuable opportunity to showcase the unique clinical strengths of Daewoong’s aesthetic products through direct engagement with local medical professionals, further reinforcing our position as a leading brand in the aesthetic field. Through the DEEP education program, which integrates education, hands-on training, and branding, we aim to drive sustainable growth in the Indonesian aesthetic market.”
# # #
